A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Insmed Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,032,562 shares of INSM stock, worth $76.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,032,562
Previous 1,325,000 22.07%
Holding current value
$76.3 Million
Previous $88.8 Million 15.09%
% of portfolio
0.14%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $18.1 Million - $23.1 Million
-292,438 Reduced 22.07%
1,032,562 $75.4 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $23.7 Million - $74.9 Million
1,075,000 Added 430.0%
1,325,000 $88.8 Million
Q1 2024

May 15, 2024

SELL
$25.72 - $29.94 $9 Million - $10.5 Million
-350,000 Reduced 58.33%
250,000 $6.78 Million
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $11.9 Million - $16.2 Million
600,000 New
600,000 $15.2 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $2.16 Million - $2.92 Million
103,500 Added 27.86%
475,000 $10.2 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $6.34 Million - $9.55 Million
371,500 New
371,500 $7.33 Million
Q3 2019

Nov 14, 2019

SELL
$15.49 - $25.78 $3.08 Million - $5.13 Million
-199,000 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$23.0 - $32.19 $5.68 Million - $7.95 Million
-247,000 Reduced 55.38%
199,000 $5.09 Million
Q1 2019

May 15, 2019

SELL
$13.91 - $31.15 $3.14 Million - $7.04 Million
-226,000 Reduced 33.63%
446,000 $13 Million
Q4 2018

Feb 14, 2019

SELL
$11.6 - $18.7 $6.7 Million - $10.8 Million
-578,000 Reduced 46.24%
672,000 $8.82 Million
Q2 2018

Aug 14, 2018

BUY
$20.0 - $29.72 $7.2 Million - $10.7 Million
360,000 Added 40.45%
1,250,000 $29.6 Million
Q1 2018

May 15, 2018

BUY
$21.69 - $32.99 $3.69 Million - $5.61 Million
169,966 Added 23.61%
890,000 $20 Million
Q4 2017

Feb 14, 2018

BUY
$26.43 - $31.78 $19 Million - $22.9 Million
720,034
720,034 $22.5 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.